Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells. Academic Article uri icon

Overview

abstract

  • Although clinical responses with CD19-targeting chimeric antigen receptor (CAR) T-cell treatment have been observed in patients with certain hematologic malignancies, high rates of disease relapse highlight the necessity to understand and improve mechanisms of CAR T-cell failure. Because T-cell dysfunction is thought to contribute to CAR T-cell treatment failure, understanding what mechanisms drive T cells into this dysfunctional state may aid optimal design of efficacious CAR T cells. Dysfunctional CAR T cells have been characterized as having upregulated inhibitory receptors and decreased cytolytic capabilities. Previous studies have identified a role for sustained CAR CD3ζ signaling in CAR T-cell dysfunction. Here, we demonstrate a mechanism that drives dysfunction in CAR T cells through excessive costimulation. Fully activated CD19-targeted CAR T cells were rendered dysfunctional upon stimulation with both endogenous CD28 stimulation and CAR-mediated CD28 costimulation. Costimulation-driven dysfunction of CAR T cells was demonstrated in a syngeneic immunocompetent mouse model, in which CAR T cells were activated with signals 1 (CD3ζ), 2 (CD28), and 3 (IL12). Thus, we show that CAR T-cell dysfunction can be driven through excessive CD28 and 4-1BB costimulation.See related article by Drakes et al., p. 743.

publication date

  • March 25, 2020

Research

keywords

  • CD28 Antigens
  • Immunotherapy, Adoptive
  • Interleukin-12
  • Lymphocyte Activation
  • T-Lymphocytes
  • Thymoma
  • Thymus Neoplasms

Identity

PubMed Central ID

  • PMC7269815

Scopus Document Identifier

  • 85085904219

Digital Object Identifier (DOI)

  • 10.1126/scisignal.aat6753

PubMed ID

  • 32213625

Additional Document Info

volume

  • 8

issue

  • 6